Clinical Practice
Popular
- NeuroFrontiers
The Evolving gMG Treatment Landscape
Henry Kaminski, MD
- NeuroFrontiers
FcRn Inhibitors: A Potential New Targeted Therapy Option
Nicholas J. Silvestri, MD, FAAN
James R. Bateman, MD, MPH
Jerome A. Barakos, MD
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
B. Joy Snider, MD, PhD
- CME/CE
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
0.50 creditsJames R. Bateman, MD, MPH
Jerome A. Barakos, MD
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
B. Joy Snider, MD, PhD
Charles P. Vega, MD
Thomas Karikari, PhD
Michele Longo, MD
Clifford Jack Jr., MD
Ashley Baker, MSN, PMHNP
Suzanne Schindler, MD
- Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
Ashley Baker, MSN, PMHNP
Vishnu Pandurangadu, MD/MBA, FACEP
Pritikanta Paul, MD
Charles Turck, PharmD, BCPS, BCCCP
Jasmohan Bajaj, MD
Charles Turck, PharmD, BCPS, BCCCP
Dr. Robert J. Shmookler Reis, PhD
Dr. Srinivas Ayyadevara, PhD
Michael Erdman, PharmD, BCCCP
Ali A. Habib, MD
Charles Turck, PharmD, BCPS, BCCCP
Nadia Merchant, MD
Melody Shi, MD
Despoina Galetaki, MD